Merck acquires global rights to SciBrunch Therapeutics’ SPR2015, a preclinical oral KRAS G12D inhibitor, in a deal worth up ...
How much of a cancer drug is too much? Patients, researchers challenge FDA-approved dosages Northwestern University economist ...
La société biopharmaceutique Celltrion prévoit de racheter 560 853 actions ordinaires pour un montant maximal de 100 ...
A thyroid tablet recall has been upgraded to the FDA’s most serious risk level after testing found the medication may be stronger than intended.
FDA Approves WELIREG Plus LENVIMA for Certain Previously Treated Adult Patients With Advanced Renal Cell Carcinoma With a Clear Cell Component (ccRCC) ...
Overton’s nomination has been criticized by abortion rights groups. In a statement released Thursday, Reproductive Freedom ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results